Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study

PURPOSE: In contrast to the Western diffuse large B-cell lymphoma (DLBCL), prognostic impact of age in a Korean population with DLBCL has not been fully evaluated. MATERIALS AND METHODS: Six hundred and eight DLBCL patients treated with rituximab-containing chemotherapeutic regimens from January 200...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res Treat
Egile Nagusiak: Hwang, Hee Sang, Kim, Meejeong, Park, Chan-Sik, Yoon, Dok Hyun, Suh, Cheolwon, Huh, Jooryung, Go, Heounjeong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812004/
https://ncbi.nlm.nih.gov/pubmed/32972046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2020.626
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak